Author:
Guo Weijun,Lu Wenlin,Xu Yujun,Wang Liansheng,Wei Qin,Zhao Qingyun
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference31 articles.
1. VanWormer JJ, Greenlee RT, McBride PE, Peppard PE, Malecki KC, Che J, et al. Aspirin for primary prevention of CVD: are the right people using it? J Fam Pract. 2012;61:525–32.
2. Wu IC, Hsieh HM, Yu FJ, Wu MC, Wu TS, Wu MT. A long-term risk-benefit analysis of low-dose aspirin in primary prevention. Eur J Clin Invest. 2016;46:130–40.
3. Sutcliffe P, Connock M, Gurung T, Freeman K, Johnson S, Kandala NB, et al. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews. Health Technol Assess. 2013;17:1–253.
4. Sutcliffe P, Connock M, Gurung T, Freeman K, Johnson S, Ngianga-Bakwin K, et al. Aspirin in primary prevention of cardiovascular disease and cancer: a systematic review of the balance of evidence from reviews of randomized trials. PLoS One. 2013;8:e81970.
5. Hayden M, Pignone M, Phillips C, Mulrow C. Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;136:161–72.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献